InnovaDerma PLC - Quality is more than skin deep

Written by Ed Stacey

InnovaDerma (LON:IDP) specialises in the development, manufacture and marketing of clinically proven products in life sciences, beauty, and personal care. The company operates a portfolio of strong innovative brands, reaching customers in the UK and Australia, and increasingly in North America, Asia, and EU.

The company listed on the LSE main board in 2016 and has delivered revenue CAGR (compound annualised growth rate) of 58% and earnings per share (EPS) CAGR of 31% in its first two years (to June 2018e).
InnovaDerma reported full-year results to June 2018 on September 19. These were in line with market expectations, with 21% like-for-like revenue growth. In this report, we focus on the drivers going forward.


Latest Research